Low-dose inhalation nitric oxide in persistent pulmonary hypertension of the newborn
- PMID: 1357246
- DOI: 10.1016/0140-6736(92)92687-b
Low-dose inhalation nitric oxide in persistent pulmonary hypertension of the newborn
Abstract
We studied the effects of inhaled nitric oxide (NO) in 9 newborn infants with severe persistent pulmonary hypertension (PPHN) who were candidates for extracorporeal membrane oxygenation treatment. With low doses of NO (10-20 ppm) all showed rapid improvement in oxygenation without reduction of systemic blood pressure. In 6 infants treated with inhaled NO for 24 h, clinical improvement was sustained at 6 ppm.
Comment in
-
Simple method for monitoring concentration of inhaled nitric oxide.Lancet. 1992 Nov 7;340(8828):1167. doi: 10.1016/0140-6736(92)93201-w. Lancet. 1992. PMID: 1359248 No abstract available.
-
Inhaled nitric oxide for postoperative pulmonary hypertension in patients with congenital heart defects.Lancet. 1992 Dec 19-26;340(8834-8835):1545. doi: 10.1016/0140-6736(92)92796-i. Lancet. 1992. PMID: 1361626 No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
